US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Clinical Trials ETF

49.32

-0.5950-1.19%

Volume:9K

Turnover:452.00K

Market Cap:46.85M

PE:- -

High:49.72

Open:49.67

Low:49.30

Close:49.91

52wk High:56.18

52wk Low:23.81

Shares:950.00K

Float Shares:950.00K

Volume Ratio:1.56

T/O Rate:0.96%

Dividend:0.65

Dividend Rate:1.33%

ROE:--

ROA:--

PB:1.06

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Dupixent’s Next Move: STYLE 1 Itch Study Wraps Up for Regeneron and Sanofi

GeoVax Updates Nasdaq Listing Amid Ongoing Clinical Progress

Psychedelic: Optimi to initiate Phase 2 trial of psilocybin-assisted therapy

Optimi Health to initiate Phase 2 trial of psilocybin-assisted therapy for MDD

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/BBC"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Clinical Trials ETF","latestPrice":49.315,"timestamp":1789147880155,"preClose":49.91,"halted":0,"volume":9126,"delay":0,"changeRate":-0.011921458625525926,"floatShares":950000,"shares":950000,"eps":0,"marketStatus":"Trading","change":-0.595,"latestTime":"09-11 13:34:49 EDT","open":49.67,"high":49.72,"low":49.3,"amount":452002.447962,"amplitude":0.008415,"askPrice":49.54,"askSize":100,"bidPrice":48.94,"bidSize":500,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789156800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":49.91,"sharesOutstanding":900004,"nav":51.382,"aum":48812941.17,"dividendRate":0.013262,"bidAskSpread":0.001886,"postHourTrading":{"tag":"盘后","latestPrice":49.91,"preClose":49.91,"latestTime":"19:30 EDT","volume":22,"amount":1105.95,"timestamp":1789083026465,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.556264,"impliedVol":0.3053,"impliedVolPercentile":0.3068},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","floatShares":950000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.556264,"shares":950000,"dividePrice":0.654,"high":49.72,"amplitude":0.008415,"preClose":49.91,"low":49.3,"week52Low":23.81,"pbRate":"1.06","week52High":56.18,"institutionHeld":0,"latestPrice":49.315,"committee":0.666667,"eps":0,"divideRate":0.013262,"volume":9126,"delay":0,"ttmEps":0,"open":49.67,"prevYearClose":38.56,"prevWeekClose":53.71,"prevMonthClose":53.05,"prevQuarterClose":52.6861,"fiveDayClose":53.39,"twentyDayClose":52.3537,"sixtyDayClose":43.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBC\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBC","amount":0.65544,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2024-12-20","symbol":"BBC","amount":0.23947,"announcedDate":"2024-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-27"},{"date":"2023-12-20","symbol":"BBC","amount":0.0823,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","recordDate":"2023-12-29","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBC\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-29","value":0.0823,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-27","value":0.23947,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-29","value":0.65544,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBC\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666057576","title":"Dupixent’s Next Move: STYLE 1 Itch Study Wraps Up for Regeneron and Sanofi","url":"https://stock-news.laohu8.com/highlight/detail?id=2666057576","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666057576?lang=en_us&edition=fundamental","pubTime":"2026-09-12 00:30","pubTimestamp":1789144227,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals ($REGN), Sanofi ($SNYNF) announced an update on their ongoing clinical study. The STYLE 1 study is a Phase 3 trial run by...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dupixents-next-move-style-1-itch-study-wraps-up-for-regeneron-and-sanofi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dupixents-next-move-style-1-itch-study-wraps-up-for-regeneron-and-sanofi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SNYNF","BBC","PSIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666446516","title":"GeoVax Updates Nasdaq Listing Amid Ongoing Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2666446516","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666446516?lang=en_us&edition=fundamental","pubTime":"2026-09-11 05:02","pubTimestamp":1789074144,"startTime":"0","endTime":"0","summary":"The latest update is out from GeoVax Labs ( ($GOVX) ). GeoVax Labs, Inc., a clinical-stage biotechnology firm listed on Nasdaq as GOVX, develops va...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/geovax-updates-nasdaq-listing-amid-ongoing-clinical-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/geovax-updates-nasdaq-listing-amid-ongoing-clinical-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","LNGR","IEIH","AGNG","BK4588","PRGS","JDOC","RSPH","IBB","LU2065732104.USD","SYNB","BBP","FHLC","BK4585","DARP","BBC","FWD","BK4097","LCLG","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666659418","title":"Psychedelic: Optimi to initiate Phase 2 trial of psilocybin-assisted therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2666659418","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666659418?lang=en_us&edition=fundamental","pubTime":"2026-09-10 22:50","pubTimestamp":1789051821,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on study initiation plans, a Breakth...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psychedelic-optimi-to-initiate-phase-2-trial-of-psilocybin-assisted-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psychedelic-optimi-to-initiate-phase-2-trial-of-psilocybin-assisted-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666910405","title":"Optimi Health to initiate Phase 2 trial of psilocybin-assisted therapy for MDD","url":"https://stock-news.laohu8.com/highlight/detail?id=2666910405","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666910405?lang=en_us&edition=fundamental","pubTime":"2026-09-10 22:25","pubTimestamp":1789050337,"startTime":"0","endTime":"0","summary":"Optimi Health (OPTH) announces plans to initiate a multisite Phase 2 clinical trial evaluating psilocybin-assisted therapy for individuals with maj...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/optimi-health-to-initiate-phase-2-trial-of-psilocybin-assisted-therapy-for-mdd-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/optimi-health-to-initiate-phase-2-trial-of-psilocybin-assisted-therapy-for-mdd-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","OPTH","HYLG","MEDX","ABVC","BK4007","IDNA","BK4139","PSIL","BBC","GDOC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":35,"pageCount":1,"totalSize":137,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BBC\",params:#limit:6,delay:false,,,undefined,":[]}}